Enerpac Tool Group Director Receives Routine Stock Grant
ENERPAC TOOL GROUP CORP
Subscribe to track EPAC
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Enerpac Director Awarded Routine Stock Grant
Company: ENERPAC TOOL GROUP CORP (EPAC) Form: 4 | Filed: 2026/02/09 Significance: Low
Insider: Cunningham Danny L Title: Not Specified | Relationship: Director
Transaction: • Type: Grant • Shares: 3,134 (Phantom Stock) • Price: $0.00 • Value: $0 • Owned After: 47,315 derivative securities
Key Insight: This is a routine, non-cash equity grant as part of the director's compensation plan. It has no immediate market impact.
Market Context: The grant represents a negligible 0.006% of total shares outstanding for the $2.25B company, resulting in minimal dilution.
Comprehensive Analysis
SEC Filing Analysis: ENERPAC TOOL GROUP CORP (EPAC)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received a routine, non-cash grant of phantom stock as part of a standard compensation plan.
- Market Impact: Neutral. This is a non-market transaction with zero cash value and negligible dilution, unlikely to influence stock price or volume.
Company Information
| Field | Value |
|---|---|
| Company | ENERPAC TOOL GROUP CORP |
| Ticker Symbol | EPAC |
| CIK | 0000006955 |
| Industry | Misc Industrial & Commercial Machinery & Equipment |
Insider Information
| Field | Value |
|---|---|
| Name | Cunningham Danny L |
| CIK | 0001671078 |
| Title/Position | Not Specified |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-02-06 |
| Transaction Code | A (Award) |
| Security Type | Phantom Stock |
| Shares Involved | 3,134 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 47,315 (derivative securities) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 3,134 |
| % of Shares Outstanding | 0.006% |
| Post-Transaction Ownership | 47,315 derivative securities (0.089% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction value is $0, making it immaterial against the company's $2.25 billion market capitalization.
- Ownership Concentration: The director's post-transaction derivative holdings represent less than 0.1% of total shares outstanding, indicating low ownership concentration from this individual.
- Dilution Impact: The grant of 3,134 shares represents approximately 0.006% of shares outstanding, resulting in a negligible dilution impact for existing shareholders.
- Transaction Significance: The transaction is a routine compensation grant, not an open-market trade, and its size is well below any threshold for significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-market award with a $0 transaction value, which is a common practice for director compensation. It does not signal any change in the insider's sentiment or outlook on the company's future performance.
Volume & Sentiment
- Expected Volume Impact: None. As a non-market grant, this filing will not directly impact trading volume.
- Sentiment Indicator: Neutral. The filing is informational and relates to standard corporate governance procedures.
Additional Context
Transaction Notes
- Special Circumstances: Per the filing's footnotes, this grant was made pursuant to the Outside Director's Compensation Plan. The director elected to defer the grant of restricted stock units, which are settled in common stock upon the director's termination of service. The phantom stock converts on a 1-for-1 basis into Class A Common Stock.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
